We are live on ! Find out more
FULC icon

Fulcrum Therapeutics
FULC

88 hedge funds and large institutions have $183M invested in Fulcrum Therapeutics in 2023 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 31 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

723% more call options, than puts

Call options by funds: $2.16M | Put options by funds: $262K

6% more capital invested

Capital invested by funds: $172M → $183M (+$11M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

7.93% less ownership

Funds ownership: 97.82% → 89.89% (-7.9%)

16% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 31

24% less funds holding

Funds holding: 116 → 88 (-28)

65% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 43

Holders
88
Holders Change
-28
Holders Change %
-24.14%
% of All Funds
1.38%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
26
Reduced
31
Closed
43
Calls
$2.16M
Puts
$262K
Net Calls
+$1.9M
Net Calls Change
+$57K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$3.81M
2
CAC
Cowen and Company
New York
+$2.76M
3
WP
Woodline Partners
California
+$1.75M
4
RI
RTW Investments
New York
+$1.62M
5
SCM
Suvretta Capital Management
New York
+$1.59M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$7.84M
2
VA
VR Adviser
New York
-$3.73M
3
CAM
Cormorant Asset Management
Massachusetts
-$3.08M
4
State Street
State Street
Massachusetts
-$2.23M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$2.19M
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$38.3M – – –
RI
2
RTW Investments
New York
$20M +$1.62M +552,284 +10%
SCM
3
Suvretta Capital Management
New York
$18.9M +$1.59M +541,171 +10%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$18.3M -$1.77M -602,588 -10%
CAC
5
Cowen and Company
New York
$10.3M +$2.76M +940,951 +43%
Vanguard Group
6
Vanguard Group
Pennsylvania
$8.67M -$742K -252,462 -9%
TGI
7
TRV GP IV
Massachusetts
$7.73M – – –
Adage Capital Partners
8
Adage Capital Partners
Massachusetts
$7.61M +$1.47M +500,000 +28%
Point72 Asset Management
9
Point72 Asset Management
Connecticut
$6.27M -$2.19M -743,704 -28%
BlackRock
10
BlackRock
New York
$5M -$7.84M -2,669,313 -64%
Citadel Advisors
11
Citadel Advisors
Florida
$4.97M +$3.81M +1,295,180 +618%
Morgan Stanley
12
Morgan Stanley
New York
$3.64M -$172K -58,494 -5%
RSCM
13
Rock Springs Capital Management
Maryland
$2.4M – – –
SAM
14
Simplify Asset Management
Nevada
$2.3M +$168K +57,178 +9%
WP
15
Woodline Partners
California
$1.97M +$1.75M +596,695 New
Two Sigma Advisers
16
Two Sigma Advisers
New York
$1.96M +$978K +332,700 +127%
Two Sigma Investments
17
Two Sigma Investments
New York
$1.91M -$211K -71,944 -11%
Millennium Management
18
Millennium Management
New York
$1.9M -$134K -45,702 -7%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$1.87M -$1.46M -496,825 -47%
VC
20
Vivo Capital
California
$1.81M – – –
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$1.57M -$821K -279,551 -37%
Goldman Sachs
22
Goldman Sachs
New York
$1.28M +$264K +89,921 +30%
Renaissance Technologies
23
Renaissance Technologies
New York
$1.14M -$133K -45,290 -12%
HMC
24
Harvard Management Company
Massachusetts
$1.13M -$202K -68,742 -17%
Bessemer Group
25
Bessemer Group
New Jersey
$947K – – –
1
2 3 4 5

FULC Hedge Fund Activity: Q2 2023 in Review

88 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Fulcrum Therapeutics (FULC) for Q2 2023, worth a combined $183M — up 6.4% from $172M a quarter earlier.

Sellers outnumbered buyers: 43 funds closed out of FULC and 15 opened new positions — a net loss of 28 holders — while 31 trimmed existing stakes and 26 added.

The largest buyer was Citadel Advisors, adding an estimated $3.81M. The largest seller was BlackRock, cutting an estimated $7.84M.

  • 88 institutional investors held Fulcrum Therapeutics (FULC) as of Q2 2023, down from 116 in Q1 2023.
  • Funds reported $183M of Fulcrum Therapeutics stock for Q2 2023, up 6.4% quarter-over-quarter.
  • 15 funds opened new Fulcrum Therapeutics positions in Q2 2023 and 43 closed out, a net change of -28 holders.
  • The largest Fulcrum Therapeutics buyer in Q2 2023 was Citadel Advisors, an estimated $3.81M added.
  • The largest Fulcrum Therapeutics seller in Q2 2023 was BlackRock, an estimated $7.84M sold.

Based on aggregated 13F filings for Q2 2023.